Cites del registre
Cita APA (7th ed.)
Liang, Y., Liu, J., Ge, J., Shi, Q., Zhang, G., Wan, A., . . . Qi, X. (2024). Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): A single-arm, phase 2 trialResearch in context. Elsevier.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Liang, Yan, et al. Safety and Efficacy of Anlotinib Combined with Taxane and Lobaplatin in Neoadjuvant Treatment of Clinical Stage II/III Triple-negative Breast Cancer in China (the NeoALTAL Trial): A Single-arm, Phase 2 TrialResearch in Context. Elsevier, 2024.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Liang, Yan, et al. Safety and Efficacy of Anlotinib Combined with Taxane and Lobaplatin in Neoadjuvant Treatment of Clinical Stage II/III Triple-negative Breast Cancer in China (the NeoALTAL Trial): A Single-arm, Phase 2 TrialResearch in Context. Elsevier, 2024.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.